2022
DOI: 10.1055/s-0042-1758385
|View full text |Cite
|
Sign up to set email alerts
|

Atrial cardiopathy and stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…There is emerging evidence that empirical anticoagulation may prevent recurrent strokes in the absence of AF when atrial cardiopathy is recognized. 50 However, there is an urgent need to clarify the threshold of clinical significance and validate criteria for defining and measuring such markers of atrial cardiopathy. In the present review, left atrial size was variably reported in several studies potentially contributing to selection bias.…”
Section: Discussionmentioning
confidence: 99%
“…There is emerging evidence that empirical anticoagulation may prevent recurrent strokes in the absence of AF when atrial cardiopathy is recognized. 50 However, there is an urgent need to clarify the threshold of clinical significance and validate criteria for defining and measuring such markers of atrial cardiopathy. In the present review, left atrial size was variably reported in several studies potentially contributing to selection bias.…”
Section: Discussionmentioning
confidence: 99%
“…AC describes functional and structural anomalies of LA [ 14 ] and is associated with several biomarkers, namely: LA enlargement, supraventricular ectopy, increase of P-wave terminal force in lead V1 (PTFV1) and increase of serum N-terminal pro-brain natriuretic peptide (NT-ProBNP) [ 15 ]. A consensual and standardized diagnostic tool has not yet been proposed.…”
Section: Introductionmentioning
confidence: 99%